Glut1 deficiency syndrome (Glut1 Deficiency Foundation)

00:00 / 00:00



Glut1 deficiency syndrome (Glut1 Deficiency Foundation)

Information for patients and families

The National Organization for Rare Disorders (NORD)

Recurrent pericarditis (NORD)

Autoimmune polyglandular syndrome type 1 (NORD)

Opsoclonus myoclonus syndrome (NORD)

Thyroid eye disease (NORD)

Bile synthesis disorders (NORD)

Cyclic vomiting syndrome (NORD)

Eosinophilic esophagitis (NORD)

Short bowel syndrome (NORD)

Essential thrombocythemia (NORD)

Myelofibrosis (NORD)

Polycythemia vera (NORD)

Sickle cell disease (NORD)

Waldenstrom macroglobulinemia (NORD)

Warm autoimmune hemolytic anemia and cold agglutinin (NORD)

Congenital athymia (NORD)

Cytomegalovirus infection after transplant (NORD)

Post-transplant lymphoproliferative disorders (NORD)

Severe chronic neutropenia (NORD)

Adrenoleukodystrophy (NORD)

Alagille syndrome (NORD)

Aromatic L-amino acid decarboxylase deficiency (NORD)

Cerebrotendinous xanthomatosis (NORD)

Classical homocystinuria (NORD)

Congenital cytomegalovirus (NORD)

Cystinuria (NORD)

Fabry disease (NORD)

Gaucher disease (NORD)

Glycogen storage disease type II (NORD)

Metachromatic leukodystrophy (NORD)

Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)

Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)

Mycobacterium avium complex (NORD)

NGLY1 deficiency (NORD)

Niemann-Pick disease types A and B (NORD)

Phenylketonuria (NORD)

PIK3CA-related overgrowth spectrum (NORD)

Tay-Sachs disease (NORD)

Zellweger spectrum disorders (NORD)

Early infantile epileptic encephalopathy (NORD)

Opsoclonus myoclonus syndrome (NORD)

Spinocerebellar ataxia (NORD)

Narcolepsy (NORD)

Focal segmental glomerulosclerosis (NORD)

IgA nephropathy (NORD)

Pulmonary arterial hypertension (NORD)


Content Reviewers


Glucose transporter type 1 deficiency syndrome, or Glut1 Deficiency, is a rare genetic disorder that impairs brain metabolism.

Glucose is not transported properly into the brain, which leaves it starving for the metabolic fuel it needs to grow, develop and function normally.

The condition is caused by over a hundred different mutations in the SLC2A1 gene, which regulates GLUT1 protein production.

And because it’s an autosomal dominant disorder, just one mutation in one of the two copies of the gene is enough to cause the disease.

Mutations mostly occur spontaneously, but affected patients do have a 50% chance of passing the altered gene to an offspring.

Now, normally GLUT1 is the primary transport protein that lets glucose cross the blood brain barrier, where the brain uses it as its main source of energy.

Without enough glucose, the brain will have impaired growth and function.

This leads to symptoms that vary widely between individuals, and can even evolve over time as patients age.

Typically, newborns are asymptomatic, but within a few months they sometimes develop irregular involuntary eye-head movements called aberrant gaze saccades or intermittent involuntary gaze, which is often a first sign of Glut1 Deficiency.

Various types of seizures are common in many patients but not always present. These seizures are usually resistant to medication treatments.

Most Glut1 Deficiency patients also have some form of movement disorder: spasticity where muscles are stiff and tense; ataxia, where balance and movement control is poor; and dystonia where muscles are contracted and twisted.

Tremors and other involuntary movements such as chorea and dyskinesia are also common, as well as floppiness due to decreased muscle tone.

Episodes of temporary paralysis on one or both sides of the body, can also occur.

These symptoms can be constant or paroxysmal, meaning intermittent, and can be triggered or worsened by excessive exercise, stress, illness, hunger, weather changes, anxiety, excitement, or fatigue.

Puberty often brings positive or negative changes in symptoms as well as changes in the response to typical treatments.


Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.